18 hours ago
Mutares SE KGaA Reports Second Quarter 2025 Earnings
Explore Mutares SE KGaA's Fair Values from the Community and select yours
Mutares SE KGaA (ETR:MUX) Second Quarter 2025 Results
Key Financial Results
Revenue: €2.38b (up 83% from 2Q 2024).
Net income: €40.8m (up from €101.2m loss in 2Q 2024).
Profit margin: 1.7% (up from net loss in 2Q 2024).
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Mutares SE KGaA Earnings Insights
Looking ahead, revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 1.3% growth forecast for the Capital Markets industry in Germany.
Performance of the German Capital Markets industry.
The company's share price is broadly unchanged from a week ago.
Risk Analysis
It is worth noting though that we have found 3 warning signs for Mutares SE KGaA that you need to take into consideration.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
